Market News AIOpen the app

InspireMD is selling shares and warrants in a deal expected to bring in about $37.5 million.

New sharesRead the original at SEC EDGAR
Bad for NSPR

InspireMD expects about $37.5 million in gross proceeds for operations, but the offering includes about 101 million shares or shares issuable through warrants. The possible increase in shares outweighs the funding benefit for current owners.

NSPR · InspireMD, Inc.

AI read · Bad for NSPR

The AI's read

The cash gives InspireMD money for research, sales, and day-to-day needs. But the offering also creates many ways for new shares to enter circulation. The pre-funded warrants can be used right away, and the common warrants can add more shares later. That possible loss of each current owner's share of the company outweighs the added cash.

Get alerts for NSPR

Follow InspireMD, Inc. (NSPR) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for NSPR
Free on the App Store and Google Play, or on the web.